Sunday 11 October 2026 Export all CME data to Excel Powerpack

CME Group Inc.

CME Financial Financial Data & Stock Exchanges

CME Group Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.5 billion, up 6.37% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS grew 2.85%, free cash flow fell 11.2% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

280.56 4.12 +1.49%
Market cap
$99.4B
P/E
23.6×
Fwd P/E
21.7×
Dividend yield
1.37%
F-score
4/9
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

Insider Decisions trades per month

Total buys 0.67
Total sells 30.01
Totals in millions of $.
Dec 25 Mar 26 Jun 26 Sep 26
Buy — 1 — — 1 — — 1 — — 1 —
Sell 2 1 — 3 3 — 2 — — — 2 —
Insider Ownership 1.69%

Capital & Financial Ratios $m

Market Cap 99,400.00
Revenue 6,772.60
Net Income 4,287.00
Free Cash Flow 4,212.70
Net Debt 1,148.60
Current Ratio 1.02
Debt/Equity 0.13
P/E ratio 23.62
Fwd P/E 21.70
P/S ratio 14.94 (above 10: high)
P/B ratio 3.82
Past 5Y EPS Growth 13.71%
This Y EPS Growth 9.58%
Next Y EPS Growth 5.61%
Next Y revenue growth 8.04%
Next 5Y EPS Growth 7.64%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

P/E against its own 10 years 21.94%
10-year low 10-year high
P/S against its own 10 years 68.13%
10-year low 10-year high
P/B against its own 10 years 97.53%
10-year low 10-year high

Dividends

Payout Ratio 0.33
Annual Dividend Rate 3.85
Annual Dividend Yield 1.37%
total individual payouts
2028 Powerpack
2027 Powerpack
2026 11.52
6.15
1.30
1.30
2025 9.72
1.25
1.25
1.25
1.25
2024 4.60
1.15
1.15
1.15
1.15
5.80
2023 4.40
1.10
1.10
1.10
1.10
5.25
2022 4.00
1.00
1.00
1.00
1.00
4.50
2021 3.60
0.90
0.90
0.90
0.90
3.25
2020 3.40
0.85
0.85
0.85
0.85
2.50
2019 3.00
0.75
0.75
0.75
0.75
2.50
2018 2.80
0.70
0.70
0.70
0.70
1.75
2017 2.64
0.66
0.66
0.66
0.66
3.50
2016 2.40
0.60
0.60
0.60
0.60
3.25
predictions special payouts not included in total or ratios

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 3,024 3,006 4,542 2,276
Receivables 536 573 639 753
Inventory — — — —
Other 91,331 99,455 160,178 158,602
94,890 103,034 165,359 161,631
2023 2024 2025 Q'26
Payables 91 80 72 68
ST’ Debt — — — —
Other 93,326 101,484 160,225 158,649
93,417 102,314 160,297 158,717

Compound Annual Growth %

10y 5y 3y
Sales 6.96% 5.95% 9.11%
Cash Flow 10.81% 9.51% 11.86%
Earnings 12.42% 13.82% 14.81%
Book Value 3.41% 1.74% 2.24%

Revenue $m

Mar Jun Sep Dec Year
’26 1,880 1,706 — — —
’25 1,642 1,692 1,538 1,649 6,521
’24 1,488 1,533 1,584 1,525 6,130
’23 1,442 1,360 1,338 1,439 5,579
’22 1,347 1,237 1,228 1,208 5,019
’21 1,253 1,179 1,110 1,147 4,690
’20 1,522 1,182 1,081 1,099 4,884
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 1,260 947 — — —
’25 1,117 1,059 968 1,134 4,277
’24 893 777 1,003 1,018 3,691
’23 902 650 857 1,044 3,454
’22 799 618 658 982 3,056
’21 603 500 632 668 2,402
’20 757 987 311 660 2,716
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 1,238 924 — — —
’25 1,102 1,040 950 1,101 4,194
’24 873 759 973 992 3,597
’23 887 630 837 1,024 3,377
’22 776 600 634 957 2,966
’21 574 460 600 680 2,315
’20 714 950 263 590 2,518
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 3.18 2.88 — — —
’25 2.62 2.81 2.49 3.24 11.16
’24 2.35 2.42 2.50 2.40 9.67
’23 2.43 2.14 2.06 2.24 8.86
’22 1.95 1.82 1.87 1.75 7.40
’21 1.60 1.42 2.58 1.71 7.29
’20 2.14 1.40 1.15 1.18 5.87
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

2.3
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trend 2026e 2027e 2028e
Price, $
Price, $ Low 81.87 113.27 143.68 161.05 131.80 177.51 166.58 166.55 190.70 224.62

Analyst estimates 2026–2028

Powerpack
High 124.01 155.29 197.08 224.91 225.36 232.64 256.94 223.80 249.02 290.79
People
People Employees 2,700 2,830 4,590 4,360 4,370 3,480 3,460 3,565 3,760 3,875
Revenue/emp, $m 1.33 1.29 0.94 1.12 1.12 1.35 1.45 1.56 1.63 1.68
Income, $m
Income, $m Revenue 3,595 3,645 4,309 4,868 4,884 4,690 5,019 5,579 6,130 6,521
Gross margin, % 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
EBT 2,288 2,526 2,778 2,690 2,722 3,374 3,490 4,154 4,541 5,331
EBT margin, % 63.63 69.31 64.46 55.25 55.74 71.94 69.54 74.45 74.08 81.75
Net income 1,534 4,063 1,964 2,116 2,106 2,637 2,691 3,226 3,526 4,072
Depreciation 225 209 249 473 464 385 363 353 337 331
Per share, $
Per share, $ Revenue 10.65 10.76 12.59 13.63 13.65 13.09 13.99 15.54 17.06 18.13
Earnings 4.55 12.00 5.73 5.93 5.88 7.30 7.41 8.87 9.69 11.18
Cash flow 5.13 5.17 7.13 7.48 7.59 6.70 8.52 9.62 10.27 11.89
Capex (0.27) (0.24) (0.34) (0.69) (0.55) (0.25) (0.25) (0.21) (0.26) (0.23)
Free cash flow 4.86 4.93 6.79 6.80 7.04 6.46 8.27 9.41 10.01 11.66
Book value 60.27 66.17 75.85 73.24 73.66 76.46 74.93 74.47 73.70 79.88
Shares, m 337 339 342 357 358 358 359 359 359 360
Valuation, ×
Valuation, × P/E 25.20 12.08 32.77 33.91 30.96 31.21 22.80 23.59 23.97 24.43
P/S 10.74 13.46 14.94 14.73 13.34 17.46 12.07 13.46 13.61 15.06
P/B 1.90 2.19 2.48 2.74 2.47 2.99 2.25 2.81 3.15 3.42
EV/Sales 10.82 13.52 15.50 15.16 13.69 17.40 12.19 13.54 13.56 14.89
EV/FCF 23.71 29.52 28.73 30.40 26.54 35.26 20.64 22.36 23.12 23.15
Cash, $m
Cash, $m Operating cash flow 1,732 1,751 2,441 2,673 2,716 2,402 3,056 3,454 3,691 4,277
Capex (92) (82) (117) (246) (197) (88) (90) (76) (94) (83)
Free cash flow 1,640 1,669 2,324 2,427 2,518 2,315 2,966 3,377 3,597 4,194
Balance, $m
Balance, $m Working capital 1,086 1,234 614 1,045 1,086 1,363 1,391 1,473 720 5,063
Total debt 2,231 2,233 3,827 3,743 3,444 2,696 3,422 3,425 2,678 3,422
Net debt 279 239 2,379 2,109 1,710 (254) 606 402 (327) (1,120)
Shareholders’ equity 20,341 22,412 25,965 26,159 26,352 27,399 26,879 26,738 26,487 28,728
Returns, %
Returns, % ROA 2.24 5.60 2.56 2.77 2.11 1.63 1.43 2.10 2.61 2.39
ROIC 6.67 6.38 5.75 5.72 5.87 6.09 6.86 7.91 9.39 9.57
ROE 7.50 19.01 8.11 8.12 8.02 9.74 9.79 11.88 13.08 14.56
Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

CME Group Inc. vs peers in Financial Data & Stock Exchanges (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
SPGI S&P Global Inc. $118.7B 24.9× 25.0× +10.41% (above 0%: growing) +16.57% (above 0%: growing) +1.23% (above 0%: growing) 71.90% 43.70% Compare
CME CME Group Inc. $99.4B 23.6× 21.7× +0.84% (above 0%: growing) +2.85% (above 0%: growing) −11.21% (below 0%: shrinking) 100.00% 64.89%
ICE Intercontinental Exchange Inc. $87.2B 21.9× 19.9× +4.84% (above 0%: growing) +14.09% (above 0%: growing) +29.65% (above 0%: growing) 98.61% 52.18% Compare
MCO Moody's Corporation $79.5B 29.3× 28.7× +15.12% (above 0%: growing) +56.52% (above 0%: growing) +47.01% (above 0%: growing) 76.29% 47.87% Compare
NDAQ Nasdaq, Inc. $51.6B 27.0× 26.1× +20.51% (above 0%: growing) +13.92% (above 0%: growing) −7.71% (below 0%: shrinking) 59.24% 28.12% Compare
COIN Coinbase Global, Inc. $45.4B — (loss-making) 359× −18.51% (below 0%: shrinking) n/m +128.50% (above 0%: growing) 84.44% (9.30%) Compare
MSCI MSCI Inc $40.8B 30.8× 30.8× +12.20% (above 0%: growing) +19.90% (above 0%: growing) +8.19% (above 0%: growing) 82.71% 56.23% Compare
CBOE Cboe Global Markets, Inc. $30.7B 23.6× — +22.95% (above 0%: growing) +50.67% (above 0%: growing) −270.85% (below 0%: shrinking) 50.71% 32.99% Compare
TRU TransUnion $12.4B 17.1× 17.1× +14.91% (above 0%: growing) +33.93% (above 0%: growing) +42.65% (above 0%: growing) 58.41% 19.70% Compare
Median of peers $48.5B 24.9× 26.1× +13.56% +19.90% +18.92% 74.10% 38.35%

All 15 Financial Data & Stock Exchanges stocks →

CME metrics, ten years each

CME Group Inc. (CME) key facts

  • Strength: CME Group Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.5 billion, up 6.37% from fiscal 2024.
  • Strength: Net income was $4.1 billion, or $11.18 per share (basic), a net margin of 61.7%.
  • CME Group Inc. (CME) is a Financial Data & Stock Exchanges company in the Financial sector, listed on Nasdaq.
  • As of October 9, 2026, CME traded at $280.56, a market capitalization of $99.4 billion.
  • At that price the stock trades at 23.6× trailing-twelve-month earnings and 14.9× sales; its P/E is higher than 22% of its own readings over the past ten years.
  • CME Group Inc. pays an annual dividend of $3.85 per share, a yield of 1.37%, with a payout ratio of 32.7%.
  • Return on equity was 14.6% and debt-to-equity 0.13.
  • Its Piotroski F-score is 4 out of 9 for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.

CME Group Inc. (CME) Latest News

7 Oct

stockrow.com/CME · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com